| Year |
Citation |
Score |
| 2022 |
Koral K, Bhushan B, Orr A, Stoops J, Bowen WC, Copeland MA, Locker J, Mars WM, Michalopoulos GK. Lymphocyte specific protein 1 suppresses xenobiotic-induced CAR and subsequent YAP activated hepatocyte proliferation. The American Journal of Pathology. PMID 35390317 DOI: 10.1016/j.ajpath.2022.03.010 |
0.39 |
|
| 2021 |
Martucci NJ, Michalopoulos GK, Mars WM. Integrin Linked Kinase (ILK) and its Role in Liver Pathobiology. Gene Expression. PMID 33482930 DOI: 10.3727/105221621X16113475275710 |
0.39 |
|
| 2020 |
Bhushan B, Molina L, Koral K, Stoops JW, Mars WM, Banerjee S, Orr A, Paranjpe S, Monga SP, Locker J, Michalopoulos GK. Yap is crucial for CAR-driven hepatocyte proliferation, but not for induction of drug metabolism genes in mice. Hepatology (Baltimore, Md.). PMID 32794202 DOI: 10.1002/Hep.31521 |
0.33 |
|
| 2020 |
Xue Y, Bhushan B, Mars WM, Bowen W, Tao J, Orr A, Stoops J, Yu Y, Luo J, Duncan A, Michalopoulos GK. p-Ezrin (Thr567) regulates Hippo pathway and Yap in liver. The American Journal of Pathology. PMID 32289287 DOI: 10.1016/J.Ajpath.2020.03.014 |
0.321 |
|
| 2020 |
Bhushan B, Koral K, Stoops JW, Mars WM, Apte UM, Michalopoulos GK. Hepatic deletion of MET aggravates acetaminophen hepatotoxicity and impairs liver regeneration in mice The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.05879 |
0.426 |
|
| 2020 |
Koral K, Bhushan B, Stoops J, Orr A, Mars W, Michalopoulos G. Lymphocyte Specific Protein‐1 suppresses TCPOBOP induced hepatocellular proliferation The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.05213 |
0.326 |
|
| 2019 |
Norris CA, He M, Kang LI, Ding MQ, Radder JE, Haynes MM, Yang Y, Paranjpe S, Bowen WC, Orr A, Michalopoulos GK, Stolz DB, Mars WM. Correction: Synthesis of IL-6 by Hepatocytes Is a Normal Response to Common Hepatic Stimuli. Plos One. 14: e0224498. PMID 31644563 DOI: 10.1371/Journal.Pone.0224498 |
0.644 |
|
| 2018 |
Koral K, Haynes M, Bowen WC, Orr A, Mars W, Michalopoulos GK. Lymphocyte-Specific Protein-1 Controls Sorafenib Sensitivity and Hepatocellular Proliferation through Extracellular Signal-Regulated Kinase 1/2 Activation. The American Journal of Pathology. 188: 2074-2086. PMID 30126548 DOI: 10.1016/J.Ajpath.2018.06.005 |
0.426 |
|
| 2018 |
Tsagianni A, Mars WM, Bhushan B, Bowen WC, Orr A, Stoops J, Paranjpe S, Tseng GC, Liu S, Michalopoulos GK. Combined Systemic Disruption of MET and Epidermal Growth Factor Receptor (EGFR) Signaling Causes Liver Failure in Normal Mice. The American Journal of Pathology. PMID 30031724 DOI: 10.1016/J.Ajpath.2018.06.009 |
0.441 |
|
| 2018 |
Bhushan B, Stoops JW, Mars WM, Orr A, Bowen WC, Paranjpe S, Michalopoulos GK. TCPOBOP-induced hepatomegaly & hepatocyte proliferation is attenuated by combined disruption of MET & EGFR signaling. Hepatology (Baltimore, Md.). PMID 29888801 DOI: 10.1002/Hep.30109 |
0.395 |
|
| 2018 |
Guzman-Lepe J, Cervantes-Alvarez E, Collin de l'Hortet A, Wang Y, Mars WM, Oda Y, Bekki Y, Shimokawa M, Wang H, Yoshizumi T, Maehara Y, Bell A, Fox IJ, Takeishi K, Soto-Gutierrez A. Liver-enriched transcription factor expression relates to chronic hepatic failure in humans. Hepatology Communications. 2: 582-594. PMID 29761173 DOI: 10.1002/hep4.1172 |
0.395 |
|
| 2016 |
Paranjpe S, Bowen WC, Mars WM, Orr A, Haynes MM, DeFrances MC, Liu S, Tseng GC, Tsagianni A, Michalopoulos GK. Combined systemic elimination of MET and EGFR signaling completely abolishes liver regeneration and leads to liver decompensation. Hepatology (Baltimore, Md.). PMID 27397846 DOI: 10.1002/Hep.28721 |
0.433 |
|
| 2015 |
Kang LI, Isse K, Koral K, Bowen WC, Muratoglu S, Strickland DK, Michalopoulos GK, Mars WM. Tissue-type plasminogen activator suppresses activated stellate cells through low-density lipoprotein receptor-related protein 1. Laboratory Investigation; a Journal of Technical Methods and Pathology. 95: 1117-29. PMID 26237273 DOI: 10.1038/Labinvest.2015.94 |
0.645 |
|
| 2015 |
Koral K, Paranjpe S, Bowen WC, Mars W, Luo J, Michalopoulos GK. Leukocyte-specific protein 1: a novel regulator of hepatocellular proliferation and migration deleted in human hepatocellular carcinoma. Hepatology (Baltimore, Md.). 61: 537-47. PMID 25234543 DOI: 10.1002/Hep.27444 |
0.429 |
|
| 2014 |
Norris CA, He M, Kang LI, Ding MQ, Radder JE, Haynes MM, Yang Y, Paranjpe S, Bowen WC, Orr A, Michalopoulos GK, Stolz DB, Mars WM. Synthesis of IL-6 by hepatocytes is a normal response to common hepatic stimuli. Plos One. 9: e96053. PMID 24763697 DOI: 10.1371/Journal.Pone.0096053 |
0.665 |
|
| 2013 |
Donthamsetty S, Bhave VS, Mars WM, Bowen WC, Orr A, Haynes MM, Wu C, Michalopoulos GK. Role of PINCH and its partner tumor suppressor Rsu-1 in regulating liver size and tumorigenesis. Plos One. 8: e74625. PMID 24058607 DOI: 10.1371/Journal.Pone.0074625 |
0.432 |
|
| 2012 |
Kang LI, Mars WM, Michalopoulos GK. Signals and cells involved in regulating liver regeneration. Cells. 1: 1261-92. PMID 24710554 DOI: 10.3390/Cells1041261 |
0.688 |
|
| 2011 |
Donthamsetty S, Mars WM, Orr A, Wu C, Michalopoulos GK. Protection against Fas-induced fulminant hepatic failure in liver specific integrin linked kinase knockout mice. Comparative Hepatology. 10: 11. PMID 22104495 DOI: 10.1186/1476-5926-10-11 |
0.331 |
|
| 2011 |
Lin CW, Mars WM, Paranjpe S, Donthamsetty S, Bhave VS, Kang LI, Orr A, Bowen WC, Bell AW, Michalopoulos GK. Hepatocyte proliferation and hepatomegaly induced by phenobarbital and 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene is suppressed in hepatocyte-targeted glypican 3 transgenic mice. Hepatology (Baltimore, Md.). 54: 620-30. PMID 21574168 DOI: 10.1002/Hep.24417 |
0.666 |
|
| 2011 |
Kang LI, Mars WM. Fibrinolytic factors in liver fibrosis. Current Pharmaceutical Biotechnology. 12: 1441-6. PMID 21401519 DOI: 10.2174/138920111798281036 |
0.682 |
|
| 2011 |
Donthamsetty S, Bhave VS, Kliment CS, Bowen WC, Mars WM, Bell AW, Stewart RE, Orr A, Wu C, Michalopoulos GK. Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene. Hepatology (Baltimore, Md.). 53: 587-95. PMID 21274879 DOI: 10.1002/Hep.24040 |
0.446 |
|
| 2010 |
Liu B, Bell AW, Paranjpe S, Bowen WC, Khillan JS, Luo JH, Mars WM, Michalopoulos GK. Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice. Hepatology (Baltimore, Md.). 52: 1060-7. PMID 20812357 DOI: 10.1002/Hep.23794 |
0.411 |
|
| 2010 |
Donthamsetty S, Bowen W, Mars W, Bhave V, Luo JH, Wu C, Hurd J, Orr A, Bell A, Michalopoulos G. Liver-specific ablation of integrin-linked kinase in mice results in enhanced and prolonged cell proliferation and hepatomegaly after phenobarbital administration. Toxicological Sciences : An Official Journal of the Society of Toxicology. 113: 358-66. PMID 19920070 DOI: 10.1093/Toxsci/Kfp281 |
0.536 |
|
| 2009 |
Apte U, Gkretsi V, Bowen WC, Mars WM, Luo JH, Donthamsetty S, Orr A, Monga SP, Wu C, Michalopoulos GK. Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology (Baltimore, Md.). 50: 844-51. PMID 19575460 DOI: 10.1002/Hep.23059 |
0.46 |
|
| 2009 |
Liu B, Paranjpe S, Bowen WC, Bell AW, Luo JH, Yu YP, Mars WM, Michalopoulos GK. Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation. The American Journal of Pathology. 175: 717-24. PMID 19574424 DOI: 10.2353/Ajpath.2009.081129 |
0.321 |
|
| 2008 |
Gkretsi V, Apte U, Mars WM, Bowen WC, Luo JH, Yang Y, Yu YP, Orr A, St-Arnaud R, Dedhar S, Kaestner KH, Wu C, Michalopoulos GK. Liver-specific ablation of integrin-linked kinase in mice results in abnormal histology, enhanced cell proliferation, and hepatomegaly. Hepatology (Baltimore, Md.). 48: 1932-41. PMID 18846549 DOI: 10.1002/Hep.22537 |
0.422 |
|
| 2007 |
Gkretsi V, Mars WM, Bowen WC, Barua L, Yang Y, Guo L, St-Arnaud R, Dedhar S, Wu C, Michalopoulos GK. Loss of integrin linked kinase from mouse hepatocytes in vitro and in vivo results in apoptosis and hepatitis. Hepatology (Baltimore, Md.). 45: 1025-34. PMID 17385211 DOI: 10.1002/Hep.21540 |
0.315 |
|
| 2005 |
Lagoa CE, Vodovotz Y, Stolz DB, Lhuillier F, McCloskey C, Gallo D, Yang R, Ustinova E, Fink MP, Billiar TR, Mars WM. The role of hepatic type 1 plasminogen activator inhibitor (PAI-1) during murine hemorrhagic shock Hepatology. 42: 390-399. PMID 16025510 DOI: 10.1002/Hep.20797 |
0.428 |
|
| 2004 |
Lagoa C, Vodovotz Y, Lhuillier F, McCloskey C, Yang R, Fink M, Stolz D, Mars W, Billiar TR. PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) CONTRIBUTES TO HEPATIC INJURY DURING HEMORRHAGIC SHOCK Shock. 21: 45. DOI: 10.1097/00024382-200406002-00133 |
0.38 |
|
| 2003 |
Lagoa C, Lhuillier F, McCloskey C, Vodovotz Y, Mars W, Yang R, Fink M, Billiar; TR. PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) IS REGULATED BY iNOS DURING HEMORRHAGIC SHOCK AND IS INVOLVED IN PRO-INFLAMMATORY SIGNALING AND TISSUE INJURY. Shock. 19: 51. DOI: 10.1097/00024382-200306001-00150 |
0.317 |
|
| 2002 |
Michalopoulos GK, Bowen WC, Mulè K, Lopez-Talavera JC, Mars W. Hepatocytes undergo phenotypic transformation to biliary epithelium in organoid cultures. Hepatology (Baltimore, Md.). 36: 278-83. PMID 12143035 DOI: 10.1053/Jhep.2002.34858 |
0.378 |
|
| 1999 |
Stolz DB, Ross MA, Salem HM, Mars WM, Michalopoulos GK, Enomoto K. Cationic colloidal silica membrane perturbation as a means of examining changes at the sinusoidal surface during liver regeneration. The American Journal of Pathology. 155: 1487-98. PMID 10550305 DOI: 10.1016/S0002-9440(10)65464-8 |
0.358 |
|
| 1997 |
Kim TH, Mars WM, Stolz DB, Petersen BE, Michalopoulos GK. Extracellular matrix remodeling at the early stages of liver regeneration in the rat Hepatology. 26: 896-904. PMID 9328311 DOI: 10.1002/hep.510260415 |
0.314 |
|
| 1995 |
Mars WM, Liu ML, Kitson RP, Goldfarb RH, Gabauer MK, Michalopoulos GK. Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration Hepatology. 21: 1695-1701. PMID 7768515 DOI: 10.1002/Hep.1840210631 |
0.413 |
|
| Show low-probability matches. |